Home » Topics » BioWorld Science

BioWorld Science
RSS

Biosion licenses BSI-04702 to OBI Pharma to develop next-generation biologics

Dec. 13, 2021

Researchers unveil GPX8 as a potential target for TNBC

Dec. 13, 2021

Pentose-phosphate pathway identified as crucial for SARS-CoV-2 virus propagation in human cells

Dec. 13, 2021

KMT2D is a therapeutic target in breast cancer

Dec. 13, 2021

Data-independent acquisition proteomics analysis reveals new associations with Alzheimer's disease

Dec. 13, 2021

Blood disorder CHIPs away Alzheimer's disease risk

Dec. 13, 2021

Bayer identifies new TRPA1 antagonists

Dec. 13, 2021

Chinook Therapeutics divulges LDHA inhibitors

Dec. 13, 2021

Targeting Tet1 leads to acute antiseizure effects in rats

Dec. 13, 2021

Sironax synthesizes RIPK1 inhibitors

Dec. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...